Gooddoctor Pharmaceutical Group

Gooddoctor Pharmaceutical Group is a major Chinese pharmaceutical enterprise headquartered in Chengdu, specializing in the integration of Traditional Chinese Medicine (TCM) with modern biotechnology. The company is globally recognized for its pioneering research into Periplaneta americana (American cockroach) extracts, which form the basis of its flagship product, Kangfuxin Liquid, used extensively for tissue repair and gastrointestinal health. The group operates a vertically integrated business model, maintaining the world's largest standardized insect breeding facilities alongside multiple GMP-certified manufacturing bases. Their product portfolio spans several therapeutic areas including pediatrics, dermatology, and hepatology. Gooddoctor continues to advance its R&D pipeline through dedicated research institutes focusing on bioactive peptides and anti-tumor applications derived from natural sources.